Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barnes

Showing results (1181-1190 of 1,346) with videos related to

Pageof 135
Sort By:
Journal of Medicinal Chemistry|May 14, 2019
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic SteatosisChristopher L Cioffi, Boglarka Racz, Andras Varadi, et al.
Circulation. Arrhythmia and Electrophysiology|June 17, 2016
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAILJames V Freeman, David W Hutton, Geoffrey D Barnes, et al.
Research and Practice in Thrombosis and Haemostasis|July 10, 2024
Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort studyJordan K Schaefer, Josh Errickson, Xiaowen Kong, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 17, 2025
Disparities in 180-day infection rates following coronary artery bypass grafting and aortic valve replacementJ'undra N Pegues, Chiang-Hua Chang, Raed M Alnajjar, et al.
Journal of Thrombosis and Thrombolysis|May 17, 2022
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
JAMA Network Open|September 19, 2022
Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for AnticoagulationJordan K Schaefer, Josh Errickson, Xiaokui Gu, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2022
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-AvibactamT A Alsenani, S L Viviani, V Kumar, et al.
Journal of the Neurological Sciences|February 17, 2000
The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosisB Sharrack, R A Hughes, R W Morris, et al.
Environmental Health Perspectives|March 6, 2012
Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart diseaseJeremy P Langrish, Xi Li, Shengfeng Wang, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane InhibitorsKhalid M Dousa, Sebastian G Kurz, Magdalena A Taracila, et al.
Pageof 135

Showing results (1181-1190 of 1,346) with videos related to

Sort By:
Pageof 135
Journal of Medicinal Chemistry|May 14, 2019
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic SteatosisChristopher L Cioffi, Boglarka Racz, Andras Varadi, et al.
Circulation. Arrhythmia and Electrophysiology|June 17, 2016
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAILJames V Freeman, David W Hutton, Geoffrey D Barnes, et al.
Research and Practice in Thrombosis and Haemostasis|July 10, 2024
Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort studyJordan K Schaefer, Josh Errickson, Xiaowen Kong, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 17, 2025
Disparities in 180-day infection rates following coronary artery bypass grafting and aortic valve replacementJ'undra N Pegues, Chiang-Hua Chang, Raed M Alnajjar, et al.
Journal of Thrombosis and Thrombolysis|May 17, 2022
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
JAMA Network Open|September 19, 2022
Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for AnticoagulationJordan K Schaefer, Josh Errickson, Xiaokui Gu, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2022
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-AvibactamT A Alsenani, S L Viviani, V Kumar, et al.
Journal of the Neurological Sciences|February 17, 2000
The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosisB Sharrack, R A Hughes, R W Morris, et al.
Environmental Health Perspectives|March 6, 2012
Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart diseaseJeremy P Langrish, Xi Li, Shengfeng Wang, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane InhibitorsKhalid M Dousa, Sebastian G Kurz, Magdalena A Taracila, et al.
Pageof 135